For nearly two decades, Alzheimer’s disease research, research funding, and prescribed drugs have been centered around a 2006 research paper hypothesizing that the cognitive decline causing the debilitating disease is due to buildup in the brain of a protein called the amyloid beta (Aβ) protein...